Mission Wealth Management LP Trims Stock Holdings in Church & Dwight Co., Inc. (NYSE:CHD)

Mission Wealth Management LP reduced its stake in Church & Dwight Co., Inc. (NYSE:CHD) by 14.1% in the fourth quarter, Holdings Channel.com reports. The fund owned 12,018 shares of the company’s stock after selling 1,968 shares during the period. Mission Wealth Management LP’s holdings in Church & Dwight were worth $1,258,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in CHD. Fidelis Capital Partners LLC grew its holdings in Church & Dwight by 4.9% during the 4th quarter. Fidelis Capital Partners LLC now owns 3,273 shares of the company’s stock valued at $348,000 after buying an additional 152 shares in the last quarter. Bellecapital International Ltd. boosted its position in shares of Church & Dwight by 13.6% in the fourth quarter. Bellecapital International Ltd. now owns 40,148 shares of the company’s stock valued at $4,204,000 after acquiring an additional 4,812 shares during the period. SBI Securities Co. Ltd. purchased a new position in Church & Dwight during the fourth quarter valued at approximately $244,000. Jones Financial Companies Lllp increased its holdings in Church & Dwight by 12.0% during the 4th quarter. Jones Financial Companies Lllp now owns 25,364 shares of the company’s stock worth $2,656,000 after acquiring an additional 2,708 shares during the period. Finally, Norden Group LLC lifted its stake in Church & Dwight by 10.0% in the 4th quarter. Norden Group LLC now owns 14,855 shares of the company’s stock worth $1,555,000 after purchasing an additional 1,348 shares in the last quarter. 86.60% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

CHD has been the subject of several analyst reports. Royal Bank of Canada reissued a “sector perform” rating and issued a $105.00 price target on shares of Church & Dwight in a report on Monday, February 3rd. Barclays boosted their target price on Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research report on Tuesday, February 4th. JPMorgan Chase & Co. decreased their target price on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a research note on Friday, February 21st. Wells Fargo & Company lifted their price target on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a research report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Church & Dwight from $114.00 to $115.00 and gave the stock a “buy” rating in a research report on Monday, November 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Church & Dwight has a consensus rating of “Hold” and a consensus price target of $111.56.

Insiders Place Their Bets

In other Church & Dwight news, EVP Michael Read bought 1,100 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The shares were bought at an average cost of $106.82 per share, with a total value of $117,502.00. Following the completion of the purchase, the executive vice president now directly owns 2,505 shares of the company’s stock, valued at $267,584.10. This trade represents a 78.29 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the business’s stock in a transaction dated Monday, December 16th. The shares were sold at an average price of $106.11, for a total value of $1,061,100.00. Following the transaction, the director now owns 32,500 shares in the company, valued at approximately $3,448,575. This represents a 23.53 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

Church & Dwight Trading Up 0.7 %

Shares of CHD opened at $112.00 on Tuesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. Church & Dwight Co., Inc. has a fifty-two week low of $96.35 and a fifty-two week high of $113.50. The firm has a 50 day moving average price of $105.84 and a 200-day moving average price of $105.12. The firm has a market cap of $27.55 billion, a price-to-earnings ratio of 47.26, a PEG ratio of 3.32 and a beta of 0.59.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter last year, the business earned $0.65 earnings per share. As a group, equities research analysts forecast that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were given a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a yield of 1.05%. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, February 14th. Church & Dwight’s dividend payout ratio (DPR) is presently 49.79%.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.